Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions

作者: Pui Yan Jenny Chung , Wim Van Hul

DOI: 10.1016/J.SEMARTHRIT.2011.07.005

关键词:

摘要: Objectives Paget's disease of bone (PDB), with a prevalence 2 to 5% in Caucasians >55 years, is the second most frequent metabolic disease, after osteoporosis. PDB characteristics are lesions an imbalanced remodeling, resulting disorganized and nonfully fledged new bone. etiology not completely understood. In this review, current views on etiology, clinical aspects, treatment summarized discussed. Methods The PubMed database was searched using keywords PDB, sequestosome1 (SQSTM1), valosin-containing protein (VCP), receptor activator nuclear factor-κB (RANK), osteoprotegerin (OPG), RANK ligand (RANKL), mutation, genetic variants, virus, osteosarcoma, bisphosphonates, denosumab. Results Environmental evidence (e.g. viruses) also risk factors have been found for PDB. Until now, SQSTM1 only PDB-causing gene identified. However, patients without mutations seem susceptibility polymorphisms regions containing CaSR , ESR1 TNFRSF11B TNFRSF11A CSF1 (M-CSF), OPTN TM7SF4 (DC-STAMP), VCP NUP205 RIN3 PML GOLGA6A genes, increased developing nature these genes indicates that regulation osteoclastogenesis key process pathogenesis. Furthermore, involvement autophagy forming aggregates, might indicate disturbance processes be factor. Conclusions Unraveling background instrumental understanding pathogenesis role slow viruses. it make early detection subsequently individuals possible.

参考文章(267)
Patricia Dargent-Molina, Franck Grados, Patrice Fardellone, Hervé Deramond, Nicolas Lecuyer, Pierre-Jean Meunier, Prevalence of Paget's disease of bone and spinal hemangioma in French women older than 75 years: data from the EPIDOS study. Joint Bone Spine. ,vol. 67, pp. 315- 318 ,(2000)
David Y. Graham, What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Digestive Diseases and Sciences. ,vol. 47, pp. 1665- 1678 ,(2002) , 10.1023/A:1016495221567
J.B Armas, F Pimentel, P.B Guyer, C Cooper, S.R Pye, T.W O’Neill, Evidence of geographic variation in the occurrence of Paget's disease. Bone. ,vol. 30, pp. 649- 650 ,(2002) , 10.1016/S8756-3282(01)00709-8
C. H. G. Price, W. Goldie, PAGET'S SARCOMA OF BONE Journal of Bone and Joint Surgery-british Volume. ,vol. 51, pp. 205- 224 ,(1969) , 10.1302/0301-620X.51B2.205
Junya Toguchida, Takao Yamamuro, Kanji Ishizaki, Masao S. Sasaki, Yoshihiko Kotoura, Yusuke Nakamura, Norihiko Takada, Noriyoshi Kawaguchi, Yasuhiko Kaneko, Toshikazu Yamaguchi, Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Research. ,vol. 52, pp. 2419- 2423 ,(1992)
Graham R Bignell, William Warren, Sheila Seal, Meiko Takahashi, Elizabeth Rapley, Rita Barfoot, Helen Green, Carolanne Brown, Patrick J Biggs, Sunil R Lakhani, Christopher Jones, Juliana Hansen, Edward Blair, Benedikt Hofmann, Reiner Siebert, Gwen Turner, D Gareth Evans, Connie Schrander-Stumpel, Frits A Beemer, Ans Van Den Ouweland, Dicky Halley, Bertrand Delpech, Mark G Cleveland, Irene Leigh, Jaakko Leisti, Sonja Rasmussen, Margaret R Wallace, Christiane Fenske, Piu Banerjee, Naoki Oiso, Ranbir Chaggar, Samantha Merrett, Niamh Leonard, Marcel Huber, Daniel Hohl, Pam Chapman, John Burn, Sally Swift, Anna Smith, Alan Ashworth, Michael R Stratton, None, Identification of the familial cylindromatosis tumour-suppressor gene. Nature Genetics. ,vol. 25, pp. 160- 165 ,(2000) , 10.1038/76006
S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok, J. Clements, A. Menzies, J.W. Teague, P.A. Futreal, M.R. Stratton, The Catalogue of Somatic Mutations in Cancer (COSMIC). Current protocols in human genetics. ,vol. 57, ,(2008) , 10.1002/0471142905.HG1011S57
A. Daroszewska, R. J. Van't Hof, L. Rose, J. Rojas, S. H. Ralston, Knock-in of the P392L mutation of SQSTM1 causes a phenotype similar to Paget's disease in mice Calcified Tissue International. ,vol. 82, ,(2008)
Keith Thompson, Michael J Rogers, Bisphosphonates and γδ t-cells: New insights into old drugs BoneKEy-Osteovision. ,vol. 3, pp. 5- 13 ,(2006) , 10.1138/20060224